Key facts
- Notable investors include Xingxiang Investment Holding Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Aifang Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Aifang Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aifang Biotechnology
Developer of biotechnology products designed to advance health and life sciences research and innovation. The company offers cutting-edge biological reagents, advanced molecular and cellular technologies, and robust research tools, enabling scientific researchers and pharmaceutical developers to accelerate discovery and improve experimental accuracy.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2020
- Website
- afantibody.cn/
- Ownership
- Privately Held (backing)
Aifang Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aifang Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aifang Biotechnology in its N-PORT filings yet. We sweep new filings monthly.